User:JSFarman/sandbox/Silvia Chiara Formenti

Silvia Chiara Formenti is an Italian American physician, radiation oncologist, and scientist. Recognized as an expert in the use of radiation therapy for the treatment of cancer, she is chair of the department of radiation and oncology professor of radiation oncology and medicine at Weill Cornell Medical College; associate director of translational research at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine; and radiation oncologist-in-chief at New York-Presbyterian Hospital.

Education
Formenti was born in Milan, Italy. She graduated suma cum laude from the Universita Degli Studi di Milan, where she earned her medical degree and achieved board certification in medical oncology, In 1984, she received a grant from the Italian National Research Council, and began her research career at the University of Southern California Norris Comprehensive Cancer Center investigating human monoclonal antibodies against colorectal cancer. She was subsequently awarded a grant from the American Cancer Society that funded a fellowship to research lymphoma and AIDS. In XXXX, she completed a residency in radiation oncology at USC and received board certification in radiation and radiation oncology.

Medicine
Affiliated with New York University from 1999 through 2015, Formenti served as Sandra and Edward H. Meyer professor and chair of the department of radiation oncology at NYU Langone Medical Center. She was also the associate director of the NYU Cancer Institute and co-leader of its Breast Cancer Research Program. In 2015, she was appointed chair of the newly established department of radiation oncology at Weill Cornell Medical College and radiation oncologist-in-chief at New York-Presbyterian/Weill Cornell Medical Center and associate director of radiation oncology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College She was later appointed associate director of translational research.

Research
Focused on radiation oncology, immunotherapy, and breast cancer research, Formenti has published more than 250 papers in journals including JAMA, The Lancet, Nature, Science and theJournal of Clinical Oncology. Among other significant findings and developments, she demonstrated the efficacy of combining radiotherapy with immunotherapy to control cancer cell growth in solid tumors; developed a raldiotherapy protocol for breast cancer that reduces damage to nearby tissues, including the heart and lung; and introduced the concept of recovering an immunological equilibrium in metastasic disease by converting a metastasis into an in situ individualized vaccine, thus establishing a link between the abscopal effect and the immune system.

Selected awards and recognition
Formenti's recent awards include the Ezra Greenspan Award from the Chemotherapy Foundation, 2022; ACR Fellowship, 2022; Society for Immunotherapy of Cancer Team Science Award, 2021; ASTRO Gold Medal for Contributions to Radiation Oncology (2019); the Laura Ziskin Prize for Translational Research, Stand Up to Cancer Foundation, 2019 and the Roentgen Prize from the Accademia dei Lincei (2019). She was elected to the American Association of Physicians in 2020.

Formenti has received research and funding awards as principal investigator from the Breast Cancer Research Foundation, the National Institute of Health, the American Cancer Society, the National Cancer Institute, the United States Department of Defense and the Patient-Centered Outcomes Research Institute, among other organizations.

She is a founding member of the International Cancer Expert Corps, a global mentorship and collaboration network that aids cancer care clinicians in lower and middle-income countries. She serves on the the steering committee of the American Association for Cancer Research.